0.34% | % of shares held by all insiders |
107.35% | % of shares held by institutions |
107.71% | % of float held by institutions |
272 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
FMR, LLC | 9,726,041 | 30 Mar 2024 | 14.76% | 362,635,437 |
Wellington Management Group, LLP | 7,647,457 | 30 Mar 2024 | 11.60% | 285,135,433 |
Blackrock Inc. | 4,511,924 | 30 Mar 2024 | 6.85% | 168,227,085 |
Vanguard Group Inc | 3,650,582 | 30 Mar 2024 | 5.54% | 136,111,949 |
Eventide Asset Management LLC | 3,119,087 | 30 Mar 2024 | 4.73% | 116,295,158 |
Price (T.Rowe) Associates Inc | 3,087,208 | 30 Mar 2024 | 4.68% | 115,106,549 |
Polar Capital Holdings PLC | 3,059,492 | 30 Mar 2024 | 4.64% | 114,073,158 |
State Street Corporation | 2,979,751 | 30 Mar 2024 | 4.52% | 111,100,015 |
Kynam Capital Management, LP | 2,900,000 | 30 Mar 2024 | 4.40% | 108,126,499 |
Bellevue Group AG | 2,796,615 | 30 Mar 2024 | 4.24% | 104,271,789 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Vanguard Specialized-Health Care Fund | 2,219,651 | 30 Jan 2024 | 3.37% | 82,759,687 |
Mutual Fund Ser Tr-Eventide Gilead Fund | 1,816,449 | 30 Dec 2023 | 2.76% | 67,726,300 |
Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 1,812,364 | 30 Dec 2023 | 2.75% | 67,573,991 |
Vanguard Total Stock Market Index Fund | 1,717,301 | 30 Dec 2023 | 2.61% | 64,029,567 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1,603,313 | 30 Mar 2024 | 2.43% | 59,779,524 |
iShares Russell 2000 ETF | 1,521,603 | 30 Mar 2024 | 2.31% | 56,732,967 |
Vanguard Explorer Fund, Inc. | 1,303,005 | 30 Jan 2024 | 1.98% | 48,582,541 |
Fidelity Select Portfolios - Biotechnology | 1,125,330 | 30 Mar 2024 | 1.71% | 41,957,928 |
Fidelity Advisor Growth Opportunities Fund | 936,700 | 30 Mar 2024 | 1.42% | 34,924,859 |
Vanguard Extended Market Index Fund | 805,231 | 30 Dec 2023 | 1.22% | 30,023,037 |